UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.

Unoki, M; Kelly, J D; Neal, D E; Ponder, B A J; Nakamura, Y; Hamamoto, R

Unoki, M; Kelly, J D; Neal, D E; Ponder, B A J; Nakamura, Y; Hamamoto, R.

Affiliation

Unoki M; Laboratory for Biomarker Development, The Institute of Physical and Chemical Research, RIKEN, Tokyo, Japan. unokim@ims.u-tokyo.ac.jp

Br J Cancer ; 101(1): 98-105, 2009 Jul 07.

Article in En | MEDLINE | ID: mdl-19491893

Subject(s)

Biomarkers, Tumor/biosynthesis; CCAAT-Enhancer-Binding Proteins/biosynthesis; Urinary Bladder Neoplasms/metabolism; Biomarkers, Tumor/genetics; CCAAT-Enhancer-Binding Proteins/genetics; Female; Humans; Immunohistochemistry; Kidney Neoplasms/genetics; Kidney Neoplasms/metabolism; Male; Neoplasm Staging; Prognosis; RNA, Messenger/biosynthesis; RNA, Messenger/genetics; Ubiquitin-Protein Ligases; Urinary Bladder Neoplasms/diagnosis; Urinary Bladder Neoplasms/genetics; Urinary Bladder Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / CCAAT-Enhancer-Binding Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Female / Humans / Male Language: En Journal: Br J Cancer Year: 2009 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google